Therapeutic Role of Tamoxifen for Triple-Negative Breast Cancer: Leveraging the Interaction Between ERβ and Mutant p53

The absence of effective therapeutic targets and aggressive nature of triple-negative breast cancer (TNBC) renders this disease subset difficult to treat. Although estrogen receptor beta (ERβ) is expressed in TNBC, studies on its functional role have yielded inconsistent results. However, recently,...

Descripción completa

Detalles Bibliográficos
Autores principales: Scarpetti, Lauren, Oturkar, Chetan C, Juric, Dejan, Shellock, Maria, Malvarosa, Giuliana, Post, Kathryn, Isakoff, Steven, Wang, Nancy, Nahed, Brian, Oh, Kevin, Das, Gokul M, Bardia, Aditya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Precision Medicine Clinic: Molecular Tumor Board
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10078911/
https://www.ncbi.nlm.nih.gov/pubmed/36772966
http://dx.doi.org/10.1093/oncolo/oyac281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10078911/
https://www.ncbi.nlm.nih.gov/pubmed/36772966
http://dx.doi.org/10.1093/oncolo/oyac281

Ejemplares similares